Dibutyrl cAMP treatment of neuroblastoma-glioma hybrid cells results in selective increase in cAMP-receptor protein (R-I) as measured by monospecific antibodies - Lohmann, S M; Schwoch, G; Reiser, G; Port, R; Walter, U (EMBO J, 1983)